Interwest Venture Management Co
- SEC CIK
- 0001697720
- Latest filing
- Oct 20, 2023
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Oct 19, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 10
- 0 vs. Q2 2021
- Portfolio value
- $241.5M
- −$75.5M (−23.8%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PMVPPMV Pharmaceuticals, Inc. | COM | 3,869,911 | $115.3M | 47.8% | −1,100,000−22.1% | Reduced | History |
| AIC3.ai, Inc. | Stock | 866,774 | $40.2M | 16.6% | 00.0% | Unchanged | History |
| REALTheRealReal, Inc. | COM | 2,354,080 | $31.0M | 12.9% | 00.0% | Unchanged | History |
| SERASera Prognostics, Inc. | CLASS A COM | 2,416,241 | $26.8M | 11.1% | +2,416,241 | New | History |
| GKOSGLAUKOS Corp | COM | 350,264 | $16.9M | 7.0% | +3,900+1.1% | Added | History |
| EIGREiger BioPharmaceuticals, Inc. | COM | 764,918 | $5.11M | 2.1% | 00.0% | Unchanged | History |
| AGTCApplied Genetic Technologies Corp | COM | 1,404,515 | $4.23M | 1.8% | 00.0% | Unchanged | History |
| VEROVenus Concept Inc. | COM | 658,657 | $1.65M | 0.7% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 8,293 | $127.0K | 0.1% | 00.0% | Unchanged | History |
| DAREDare Bioscience, Inc. | COM | 62,065 | $104.0K | <0.1% | +11,697+23.2% | Added | History |
Sold out since Q2 2021 (1)
Positions held at the end of Q2 2021 that are gone from this filing.